2.22  0.88 (65.67%)		06-02 16:00
Open: 1.49 High: 2.45 Volume: 36,422,007		Pre. Close: 1.34 Low: 1.4 Market Cap: 42(M)

Short term
Mid term
Targets	6-month :	2.86	1-year :	3.34
Resists	First :	2.45	Second :	2.86
Pivot price	0.97
Supports	First :	1.26	Second :	0.54
MAs	MA(5) :	1.62	MA(20) :	0.9
	MA(100) :	0.89	MA(250) :	1.15
MACD	MACD :	0.2	Signal :	0
%K %D	K(14,3) :	64.2	D(3) :	63.7
RSI	RSI(14): 80.9
52-week	High :	2.45	Low :	0.48

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ RKTO ] has closed above the upper band by 12.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 495.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	2.45 - 2.46	2.46 - 2.48
Low:	1.38 - 1.39	1.39 - 1.4
Close:	2.2 - 2.22	2.22 - 2.24

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in Hoboken, NJ.

Tue, 02 Jun 2026
Rocket One (Nasdaq: RKTO) adds nanomagnetics expert as lead advisor - Stock Titan

Sat, 30 May 2026
Rocket One Inc. Common Stock (RKTO) Stock Price, News & Analysis - MarketBeat

Fri, 29 May 2026
Debt to equity ratio of Hoth Therapeutics, Inc. – NASDAQ:RKTO - TradingView

Thu, 28 May 2026
Rocket One Inc. (RKTO) CEO receives grant of 550,000 stock options - Stock Titan

Thu, 28 May 2026
Rocket One Inc. (RKTO) director receives 75,000 fully vested stock options - Stock Titan

Thu, 28 May 2026
Hoth Therapeutics’ pivot to AI in space sees stock price rocket - Fierce Biotech

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ Global Market
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.